Relevance of benign prostatic hyperplasia and associated conditions for urologists, health care systems, and society

por Oelke, Matthias, Gravas, Stavros
Publicado 2010

Current status of 5α-reductase inhibitors in the management of lower urinary tract symptoms and BPH

por Gravas, Stavros, Oelke, Matthias
Publicado 2009

What do we really know about benign prostatic hyperplasia and lower urinary tract symptoms in adult men?

por Oelke, Matthias, Michel, Martin C.
Publicado 2011

Which drugs are best for overactive bladder? From patients’ expectations to physicians’ decisions

por Milsom, Ian, Wagg, Adrian, Oelke, Matthias, Chapple, Christopher
Publicado 2020

Nocturia is often inadequately assessed, diagnosed and treated by physicians: results of an observational, real‐life practice database containing 8659 European and US‐American pati...

por Oelke, Matthias, Anderson, Peter, Wood, Robert, Holm‐Larsen, Tove
Publicado 2016

The fish-hook configuration of the distal ureter indicates bladder outlet obstruction due to benign prostatic hyperplasia

por Mamoulakis, Charalampos, Herrmann, Thomas R. W., Höfner, Klaus, Oelke, Matthias
Publicado 2010

What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesotero...

por Wagg, Adrian S., Herschorn, Sender, Carlsson, Martin, Fernet, Mireille, Oelke, Matthias
Publicado 2021

Efficacy of propiverine ER with or without α-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional study

por Oelke, Matthias, Murgas, Sandra, Baumann, Ina, Schnabel, Frieder, Michel, Martin C.
Publicado 2011

Factors Associated with Decisions for Initial Dosing, Up-Titration of Propiverine and Treatment Outcomes in Overactive Bladder Syndrome Patients in a Non-Interventional Setting

por Amiri, Marjan, Schneider, Tim, Oelke, Matthias, Murgas, Sandra, Michel, Martin C.
Publicado 2021

Manual versus automatic bladder wall thickness measurements: a method comparison study

por Oelke, Matthias, Mamoulakis, Charalampos, Ubbink, Dirk T., de la Rosette, Jean J., Wijkstra, Hessel
Publicado 2009

Intradetrusor onabotulinumtoxinA injections are significantly more efficacious than oral oxybutynin for treatment of neurogenic detrusor overactivity: results of a randomized, cont...

por Ferreira, Rúiter Silva, D’Ancona, Carlos Arturo Levi, Oelke, Matthias, Carneiro, Maurício Rassi
Publicado 2018

Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus valida...

por Oelke, Matthias, Becher, Klaus, Castro-Diaz, David, Chartier-Kastler, Emmanuel, Kirby, Mike, Wagg, Adrian, Wehling, Martin
Publicado 2015

Annual direct and indirect costs attributable to nocturia in Germany, Sweden, and the UK

por Weidlich, Diana, Andersson, Fredrik L., Oelke, Matthias, Drake, Marcus John, Jonasson, Aino Fianu, Guest, Julian F.
Publicado 2016

Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated T...

por Brock, Gerald, Ni, Xiao, Oelke, Matthias, Mulhall, John, Rosenberg, Matt, Seftel, Allen, D’Souza, Deborah, Barry, Jane
Publicado 2016

Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS: A...

por Drake, Marcus J., Oelke, Matthias, Snijder, Robert, Klaver, Monique, Traudtner, Klaudia, van Charldorp, Karin, Bongaerts, Dominique, Van Kerrebroeck, Philip
Publicado 2017

What Are Realistic Expectations to Become Free of Overactive Bladder Symptoms? Experience from Non-interventional Studies with Propiverine

por Müderrisoglu, A. Elif, Oelke, Matthias, Schneider, Tim, Murgas, Sandra, de la Rosette, Jean J. M. C. H., Michel, Martin C.
Publicado 2022

A practical approach to the management of nocturia

por Oelke, Matthias, De Wachter, Stefan, Drake, Marcus J., Giannantoni, Antonella, Kirby, Mike, Orme, Susan, Rees, Jonathan, van Kerrebroeck, Philip, Everaert, Karel
Publicado 2017

The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction

por Gacci, Mauro, Salvi, Matteo, Sebastianelli, Arcangelo, Vignozzi, Linda, Corona, Giovanni, McVary, Kevin T, Kaplan, Steven A, Maggi, Mario, Carini, Marco, Oelke, Matthias
Publicado 2013

Impact of disease progression on individual IPSS trajectories and consequences of immediate versus delayed start of treatment in patients with moderate or severe LUTS associated wi...

por D’Agate, Salvatore, Wilson, Timothy, Adalig, Burkay, Manyak, Michael, Palacios-Moreno, Juan Manuel, Chavan, Chandrashekhar, Oelke, Matthias, Roehrborn, Claus, Della Pasqua, Oscar
Publicado 2019

Model‐based meta‐analysis of individual International Prostate Symptom Score trajectories in patients with benign prostatic hyperplasia with moderate or severe symptoms

por D'Agate, Salvatore, Wilson, Timothy, Adalig, Burkay, Manyak, Michael, Palacios‐Moreno, Juan Manuel, Chavan, Chandrashekhar, Oelke, Matthias, Roehrborn, Claus, Della Pasqua, Oscar
Publicado 2020